SGLT-2抑制剂治疗糖尿病肾病的研究进展(5)
[23] Kashiwagi A，Takahashi H，Ishikawa H，et al. A randomized，double-blind，placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment：results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment(LANTERN)study [J]. Diabetes Obes Metab ......
您现在查看是摘要页，全文长 1968 字符。